Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
S
Sinovac Biotech Ltd. SVA
$6.47
โ–ฒ +0.00% 24H
0.752.995.237.479.712003-092009-052015-022020-102026-06

About

Sinovac Biotech Ltd. is a prominent biotechnology company that specializes in the research, development, manufacturing, and commercialization of vaccines to address human infectious diseases. Headquartered in Beijing, China, Sinovac plays a critical role in the global health market by developing vaccines for illnesses โ€ฆ

Sectorโ€”
ExchangeNASDAQ
Industryโ€”
CountryUnited States
Employees0
TickerSVA

Statistics

Market Cap$464.9M
Revenue (TTM)$386.0M
Net Income-$198.8M
Net Margin-51.5%
EPS$-0.83
P/E6.66
P/S1.20
P/B0.10
EV/EBITDA9.35
ROE-0.9%
Dividend Yieldโ€”
Price$6.47

Data: Twelve Data ยท Revenue = mcap / P/S

Sinovac Biotech Ltd. (SVA) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap